课题基金 / 基金详情

Core--Embryonic Stem Cell Gene Manipulation

Core--Embryonic Stem Cell Gene Manipulation
核心--胚胎干细胞基因操控
批准号:
7312581
负责人:
Gerald W. Dorn
金额:
$43.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-01-01 至 2009-12-31

项目摘要

项目成果

Gerald W. Dorn的其他基金

相似基金

相关文献

中文摘要
翻译
在SCCOR提案的主题中,在其发展中发挥重要作用的一个主题是描绘关键的心脏信号通路,并在这些通路的组成部分中识别改变心力衰竭易感性或进展的人类遗传多态性。我们的研究小组已经应用了系统的垂直整合分析,以确定心脏信号和钙处理基因的新多态性,定义与特定临床特征或结果的关联,使用体外表达系统确定这些多态性的功能效应,并建立这些多态性在完整的生物系统中的病理生理学效应,即遗传操作的小鼠和兔。虽然关联和病例对照人类研究推动了这些研究,并将明确提供生物学框架, 机制研究,发展合适的小鼠模型将允许实验 在人类受试者中根本无法获得的个体基因变异上进行。为了促进这种垂直科学方法,Core D将对小鼠基因组进行复杂的操作,以便为SCCOR研究人员的机制研究生成最佳小鼠模型,包括条件和常规敲除,敲入,多基因取代和靶向转基因。为了支持SCCOR项目,核心将协助设计靶向策略,将设计靶向载体,将电穿孔,选择和识别靶向ES细胞,并将进行囊胚注射以产生嵌合小鼠。
英文摘要
Among the themes of this SCCOR proposal, one that has played a major role in its development is the delineation of critical cardiac signaling pathways and identification, in the components of these pathways, of human genetic polymorphisms that modify the susceptibility to, or progression of, heart failure. Our group of investigators has applied a systematic vertically-integrated analysis for identifying novel polymorphisms in cardiac signaling and calcium-handling genes, defining associations with specific clinical features or outcomes, determining the functional effects of these polymorphisms using in vitro expression systems, and establishing the pathophysiological effects of these polymorphisms in intact biological systems, i.e. genetically manipulated mice and rabbits. Although associative and case-control human studies drive these investigations, and will clearly provide the biological framework for mechanistic studies, the development of suitable mouse models will permit experiments to be performed on individual gene variants that are simply not attainable with human subjects. To facilitate this vertical scientific approach, Core D will perform complex manipulations of the mouse genome in order to generate optimal mouse models for the SCCOR investigators' mechanistic studies, including conditional and conventional knock-outs, knock-ins, multi-gene substitutions, and targeted transgenesis. In support of the SCCOR projects, the Core will assist in the design of targeting strategies, will engineer targeting vectors, will electroporate, select for and identify targeted ES cells, and will perform blastocyst injection for generation of chimeric mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitofusin Agonists to Treat Neurodegenerative Disease
  • 批准号:
    10383118
  • 项目类别:
  • 资助金额:
    $96.87万
  • 财政年份:
    2022
  • 负责人:
    Gerald W. Dorn
  • 依托单位:
Mitofusin Agonists to Treat Neurodegenerative Disease
  • 批准号:
    10618385
  • 项目类别:
  • 资助金额:
    $98.62万
  • 财政年份:
    2022
  • 负责人:
    Gerald W. Dorn
  • 依托单位:
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE
  • 批准号:
    10290982
  • 项目类别:
  • 资助金额:
    $7.85万
  • 财政年份:
    2021
  • 负责人:
    Gerald W. Dorn
  • 依托单位:
Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A
  • 批准号:
    10471364
  • 项目类别:
  • 资助金额:
    $90.18万
  • 财政年份:
    2019
  • 负责人:
    Gerald W. Dorn
  • 依托单位:
海外基金